DD

David Dwane Voris

Active Director Alternate Director DIN 10409792
DIN 10409792 First appointment Dec 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value •••• Premium profile

About David Dwane Voris

Data last updated:

David Dwane Voris is an Alternate Director at Shifamed India Private Limited (since 2023). Shifamed India Private Limited reported revenue of ₹3.84 Cr (FY 2025).

DIN 10409792
Primary Designation Alternate Director
First Appointment 06 Dec 2023
Oldest Company Age 3 yrs
Largest company Shifamed India Private Limited · ₹3.84 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shifamed India Private Limited U58201KA2023FTC201714
Alternate Director06 Dec 20232023₹3.84 Cr (FY 2025)Active

Board colleagues of David Dwane Voris

Directorship timeline

Open interactive timeline →
Shifamed India Private Limited
Premium access

Shareholding and investment profile for David Dwane Voris

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about David Dwane Voris

David Dwane Voris currently holds 1 directorship: Shifamed India Private Limited (Alternate Director, since 06 Dec 2023, revenue ₹3.84 Cr (FY 2025)).

David Dwane Voris was first appointed on 06 Dec 2023 as Alternate Director at Shifamed India Private Limited.

The current boards of David Dwane Voris's companies include Amrou Salahieh (Shifamed India Private Limited), Sidda Made Gowda Shivaraj (Shifamed India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available